2-(4-tert-Butylphenyl)-5-(4-biphenyl)-1,3,4-oxadiazole(15082-28-7)
- Name: 2-(4-tert-Butylphenyl)-5-(4-biphenyl)-1,3,4-oxadiazole
- Synonyms:1,3,4-Oxadiazole,2-(4-biphenylyl)-5-(p-tert-butylphenyl)- (8CI);2-(4-Biphenyl)-5-(4-tert-butylphenyl)-1,3,4-oxadiazole;2-(4-Biphenylyl)-5-(4-t-butylphenyl)-1,3,4-oxadiazole;2-(4-Biphenylyl)-5-(4-tert-butylphenyl)-1,3,4-oxadiazole;2-(4-Biphenylyl)-5-(4-tertiary-butylphenyl)-1,3,4-oxadiazole;2-(4-tert-Butylphenyl)-5-(4-biphenyl)-1,3,4-oxadiazole;2-(4-tert-Butylphenyl)-5-(4'-biphenyl)-1,3,4-oxadiazole;2-(4'-tert-Butylphenyl)-5-(4-biphenylyl)-1,3,4-oxadiazole;2-[1,1'-Biphenyl]-4-yl-5-(4'-tert-butyl)phenyl-1,3,4-oxadiazole;5-(4-tert-Butylphenyl)-2-(biphenyl-4-yl)-1,3,4-oxadiazole;Butyl-PBD;NSC158164;tert-Butylphenyl-p-biphenyloxadiazole;
- Molecular Formula:C24H22N2O
- Molecular Weight:354.451
- CAS Registry Number:15082-28-7
- EINECS:239-135-7
- Melting Point:137-139 °C
- Water Solubility:toluene: 0.1 g/mL, clear, colorless

Other Product
- 59139-23-0/Ethanol,2-amino-,compounds,compd. with R-(nonylphenyl)-ö-hydroxypoly(oxy-1,2- ethanediyl) phosphate
- 68214-36-8/Abietic acid, fumaric acid adducts glycerol, diethylene glycol polymer
- 69012-77-7/Leach solutions, molybdenum, spent sulfate
- 22562-97-6/Dammar-25-en-3-one,20,24-epoxy-, (20R,24R)- (8CI,9CI)
- 5138-61-4/3-(3-chlorophenyl)-1-[3-(3-chlorophenyl)-5,5-dimethyl-1-(2-methylpropyl)-2-oxoimidazolidin-4-yl]-1-hydroxyurea
- 52036-37-0/dibutyl(cyclohexyl)hexylgermane
- 35786-42-6/1-hexopyranosyl-1H-imidazole
- 42021-34-1/Biriperone
- 68987-47-3/Toluene diisocyanate, hydroxy-terminated polybutadiene reaction product
- 55755-92-5/2-iodo-N-[4-[(2-iodoacetyl)amino]butyl]acetamide
- 105579-74-6/altertoxin III
- 83850-78-6/ACETAMIDE, 2-(p-CHLOROANILINO)-N-(2-(DIMETHYLAMINO)ETHYL)-2-PHENYL-
- 62200-13-9/E021
- 26555-35-1/thiocarbonic acid, anhydrosulphide with ethyl thiohypochlorite
- 115803-60-6/baliz 2
- 99671-97-3/6,9-dimethyl-3-(4-methylpent-3-en-1-yl)benzo[de]chromene-7,8-dione
- 73483-87-1/(4aS)-3,4,4a,5,6,7,8,8a-Octahydro-2,5-dimethyl-5α-(4-methyl-3-pentenyl)-1,8aβ-naphthalenedicarbaldehyde
- 108354-78-5/2-AMINO-4,5,6,7-TETRAHYDRO-BENZO[B]THIOPHENE-3-CARBOXYLIC ACID METHYL ESTER
- 15082-28-7/2-(4-tert-Butylphenyl)-5-(4-biphenyl)-1,3,4-oxadiazole
- 125239-14-7/b-D-Glucopyranoside,(1aS,1bS,2S,5aR,6S,6aS)-6-[[2-O-acetyl-6-deoxy-3-O-[(2E)-3-(3-hydroxy-4-methoxyphenyl)-1-oxo-2-propenyl]-a-L-mannopyranosyl]oxy]-1a,1b,2,5a,6,6a-hexahydro-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl(9CI)
- 115271-30-2/Hexanedioic acid, polymerwith 1,4-butanediol, 1,6-diisocyanatohexane, 1,2-ethanediamine,5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, a,a'-[(1-methylethylidene)di-4,1-phenylene]bis[w-hydroxypoly[oxy(methyl-1,2-ethanediyl)]]and 2-methyloxirane, polyethylene-polypropylene glycol mono-Bu ether-blocked
- 16910-39-7/Cholest-8-en-3-ol,4,14-dimethyl-, (3b,4a,5a)-
- 82619-59-8/2-[4-(10H-pyrido[3,2-b]thieno[3,4-e][1,4]diazepin-6-yl)piperazin-1-yl]ethanol (2E)-but-2-enedioate (salt)
- 31788-88-2/(2-AMINO-2-PHENYLETHYL)DIMETHYLAMINE
- 15650-04-1/Spiro[cyclohexane-1,1'(2'H)-cyclopenta[ij][1,3]dioxolo[4,5-g]isoquinolin]-4-ol,2'a,3',4',5'-tetrahydro-, (1a,2'aR,4b)-
- 90990-37-7/Fatty acids, C12-20 and C12-20-unsatd., compds. with triethanolamine
- 59988-03-3/N-[4-(acridin-9-ylamino)-3-methoxyphenyl]propane-1-sulfonamide methanesulfonate (1:1)
- 69011-69-4/Cadmium dross
- 81811-55-4/HINC II 5'...GTPY/PUAC...3'
- 499212-74-7/Pritumumab